Daiichi Sankyo Company, Limited

4568.T · Moat type: REGULIERUNG

MoatScore

5/10

Fair Value

1,833 JPY (≈ 11.36 USD)

Margin of Safety

-46.1 %

Rating

BEOBACHTEN

Daiichi Sankyo is a Japanese pharmaceutical company that develops, produces, and markets high-revenue prescription medications through patents and regulatory approvals, with recent focus on antibody-drug conjugates (ADCs) in the oncology sector.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.